Meta-analysis of Efficacy and Safety Outcomes Associated With the Basal-Plus Regimen of Insulin Glargine and Insulin Glulisine among Type 2 Diabetes Patients With HbA1c≥8%

被引：0
|
作者：
Raccah, Denis
Lin, Jay
Bahloul, Amar
Wang, Edward
Penfornis, Alfred
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2464-PO
引用
收藏
页码：A620 / A620
页数：1
相关论文
共 50 条
  • [41] Resistance Exercise Intensity is Correlated with Attenuation of HbA1c and Insulin in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
    Liu, Yubo
    Ye, Weibing
    Chen, Qian
    Zhang, Yong
    Kuo, Chia-Hua
    Korivi, Mallikarjuna
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2019, 16 (01)
  • [42] Contribution of fasting and postprandial plasma glucose to HbA1c in people with type 2 diabetes on basal-bolus insulin: a meta-analysis of insulin lispro clinical trials
    Liao, B.
    Chen, Y.
    Chigutsa, F.
    de Oliveira, C. Piras
    [J]. DIABETOLOGIA, 2020, 63 (SUPPL 1) : S332 - S332
  • [43] The efficacy and safety of LY2963016 insulin glargine in patients with type 1 and type 2 diabetes previously treated with insulin glargine
    Hadjiyianni, I.
    Asaro-Harris, A.
    Dahl, D.
    Lacaya, L. B.
    Pollom, R. K.
    Ilag, L. L.
    Zielonka, J. S.
    [J]. DIABETOLOGIA, 2015, 58 : S469 - S469
  • [44] Efficacy and safety of LY2963016 insulin glargine in patients with type 1 and type 2 diabetes previously treated with insulin glargine
    Hadjiyianni, I.
    Dahl, D.
    Lacaya, L. B.
    Pollom, R. K.
    Chang, C. L.
    Ilag, L. L.
    [J]. DIABETES OBESITY & METABOLISM, 2016, 18 (04): : 425 - 429
  • [45] Hypoglycaemia as a function of HbA1c, in type 2 diabetes: insulin glargine 300 U/ml in a patient-level meta-analysis of EDITION 1, 2 and 3
    Choudhary, P.
    Bonadonna, R.
    Yale, J. -F.
    Brulle-Wohlhueter, C.
    Boelle-Le Corfec, E.
    Bailey, T. S.
    [J]. DIABETOLOGIA, 2016, 59 : S6 - S7
  • [46] Efficacy and safety of subgroup analysis stratified by baseline HbA1c in a Japanese phase 3 study of dulaglutide 0.75 mg compared with insulin glargine in patients with type 2 diabetes
    Kaneko, Shizuka
    Oura, Tomonori
    Matsui, Akiko
    Shingaki, Tomotaka
    Takeuchi, Masakazu
    [J]. ENDOCRINE JOURNAL, 2017, 64 (12) : 1165 - 1172
  • [47] Efficacy and safety of insulin detemir versus glargine in patients with diabetes: a systematic review and meta-analysis
    Rezaei, Soheila
    Taheri, Ali
    Taheri, Saeed
    Kasirzadeh, Sara
    Fatemi, Behzad
    Sorato, Mende M.
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2022, 15 (06) : 767 - 777
  • [48] Meta-analysis of basal insulin plus Acarbose versus premixed insulin in the treatment of type 2 diabetes
    唐黎之
    [J]. China Medical Abstracts (Internal Medicine), 2017, 34 (02) : 93 - 93
  • [49] THE ASSOCIATION BETWEEN NON-ADHERENCE AND HBA1C AMONG TYPE 2 DIABETES PATIENTS USING BASAL INSULIN ANALOGUES
    DiBonaventura, M. D.
    Wintfeld, N.
    Goren, A.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A182 - A182
  • [50] Factors associated with reaching or not reaching target HbA1c after initiation of basal or premixed insulin in patients with type 2 diabetes
    Scheen, A. J.
    Schmitt, H.
    Jiang, H. H.
    Ivanyi, T.
    [J]. DIABETES & METABOLISM, 2017, 43 (01) : 69 - 78
12345